Sandeep Chidambar Kulkarni, CEO at Tourmaline Bio, Inc. (TRML), bought 9,650 shares at $12.25 ($111K) on 2023-10-26, disclosed to the SEC on 2023-10-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.68 | 4,650 | $50K | 44.8% |
| 2 | $12.25 | 5,000 | $61K | 55.2% |
| Total | $11.49 avg | 9,650 | $111K | 100% |
| Filing → |
| TRML | BUY | 2023-11-20 | $68K | — | Filing → |